Skip to main content
SYNLOGIC, INC. logo

SYNLOGIC, INC. — Investor Relations & Filings

Ticker · SYBX ISIN · US87166L1008 US Manufacturing
Filings indexed 615 across all filing types
Latest filing 2024-11-12 Registration Form
Country US United States of America
Listing US SYBX

About SYNLOGIC, INC.

https://www.synlogictx.com/

Synlogic, Inc. is a biopharmaceutical company that pioneers the development of Synthetic Biotics, a novel class of living medicines. By applying the principles of synthetic biology, the company engineers beneficial microbes to perform specific therapeutic functions directly within the gastrointestinal tract. These orally administered, non-systemically absorbed biotherapeutics are designed to treat serious metabolic and rare diseases by consuming toxic substances or producing therapeutic compounds. Synlogic's approach operates at the intersection of biology and engineering, aiming to program living cells to address the underlying drivers of disease in innovative ways.

Recent filings

Filing Released Lang Actions
S-8
Registration Form
2024-11-12 English
S-8
Registration Form
2024-11-12 English
10-Q
Interim / Quarterly Report Q3 2024
2024-11-12 English
8-K
Regulatory Filings
2024-11-12 English
DEF 14A
Proxy Solicitation & Information Statement
2024-11-06 English
ARS
Annual Report
2024-11-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.